Evidence map›Paper›PMID 35500034›Full record

ArticlePLoS genetics2022

Assessing in vivo mutation frequencies and creating a high-resolution genome-wide map of fitness costs of Hepatitis C virus.

Kaho H Tisthammer, Caroline Solis, Faye Orcales, Madu Nzerem, Ryan Winstead, Weiyan Dong, Jeffrey B Joy, Pleuni S Pennings

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kaho H TisthammerDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0002-4530-4572
Caroline SolisDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.
Faye OrcalesDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0002-9326-1001
Madu NzeremDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0001-7150-5813
Ryan WinsteadDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.
Weiyan DongBC Centre for Excellence in HIV/AIDS, Vancouver, British Colombia, Canada.ORCID 0000-0003-1718-470X
Jeffrey B JoyBC Centre for Excellence in HIV/AIDS, Vancouver, British Colombia, Canada.ORCID 0000-0002-7013-1482
Pleuni S PenningsDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0001-8704-6578
San Francisco State University · USAIDS Vancouver · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Like many viruses, Hepatitis C Virus (HCV) has a high mutation rate, which helps the virus adapt quickly, but mutations come with fitness costs. Fitness costs can be studied by different approaches, such as experimental or frequency-based approaches. The frequency-based approach is particularly useful to estimate in vivo fitness costs, but this approach works best with deep sequencing data from many hosts are. In this study, we applied the frequency-based approach to a large dataset of 195 patients and estimated the fitness costs of mutations at 7957 sites along the HCV genome. We used beta regression and random forest models to better understand how different factors influenced fitness costs. Our results revealed that costs of nonsynonymous mutations were three times higher than those of synonymous mutations, and mutations at nucleotides A or T had higher costs than those at C or G. Genome location had a modest effect, with lower costs for mutations in HVR1 and higher costs for mutations in Core and NS5B. Resistance mutations were, on average, costlier than other mutations. Our results show that in vivo fitness costs of mutations can be site and virus specific, reinforcing the utility of constructing in vivo fitness cost maps of viral genomes.

Indexed as

HepacivirusHepatitis CGenome, ViralHumansMutationMutation Rate

Identifiers

PMID35500034
PMCPMC9113599
OpenAlexW4225284589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.